Ketogenic diet shows promise in curbing cravings in alcohol use disorder patients

Study found that a ketogenic diet (KD) significantly increased serum beta-hydroxybutyrate levels, suggesting nutritional ketosis, and showed a trend towards reducing self-reported alcohol craving and a neurobiological craving signature (NCS) for alcohol in patients with alcohol use disorder (AUD), indicating its potential to modulate alcohol craving.

Imperial spinout NK:IO awarded £1.6M Innovate UK New Cancer Therapeutics grant for development of pioneering NK cell therapy

NK:IO, a leader in NK cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumors, today announced it has been

July 11, 2023

Cybin Initiates PARADIGM: A Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder and Reports Second Quarter Financial Results | Psychedelic Invest

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation

November 13, 2024

Billing for Patient Messages May Have Negative Consequences, Analysis Suggests

Billing patients for patient portal messaging services may have negative consequences for both patients and physicians, according to a qualitative analysis. Looking at survey responses

October 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.